GlassScriptPhysician profile
Raymond N Fernandez
NPI 1699774141
$2,991.62
in general payments reported to CMS, 2019-2025
22 companies · $567 in 2025
The $567 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $169 · 2021: $173 · 2022: $514 · 2023: $518 · 2024: $692 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $913.97 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $520.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $317.77 | 2022-2025 | Verquvo |
| Irhythm Technologies, INC. | $198.53 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $186.11 | 2019-2025 | Farxiga |
| Amgen INC. | $166.54 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $115.48 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $103.18 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $91.02 | 2024-2025 | |
| Esperion Therapeutics, INC. | $75.19 | 2020-2025 | Nexletol |
| Biotronik INC. | $56.37 | 2019-2022 | |
| Medtronic, INC. | $39.83 | 2022-2024 | Hawkone |
| Regeneron Healthcare Solutions, INC. | $30.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.19 | 2019 | |
| Abbott Laboratories | $27.04 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $24.22 | 2021 | |
| Philips North America LLC | $17.51 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Daiichi Sankyo INC. | $17.51 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.34 | 2025 | |
| Baxter Healthcare | $16.43 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Amarin Pharma, INC. | $15.07 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.